Swiss National Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-28,530
Closed -$2.78M 2630
2015
Q1
$2.78M Buy
28,530
+7,530
+36% +$735K 0.01% 1089
2014
Q4
$1.95M Buy
21,000
+600
+3% +$55.7K 0.01% 1276
2014
Q3
$1.4M Sell
20,400
-500
-2% -$34.4K 0.01% 1448
2014
Q2
$2.19M Hold
20,900
0.01% 1196
2014
Q1
$1.73M Buy
20,900
+5,800
+38% +$481K 0.01% 1301
2013
Q4
$977K Hold
15,100
﹤0.01% 1522
2013
Q3
$956K Buy
15,100
+1,300
+9% +$82.3K ﹤0.01% 1478
2013
Q2
$580K Buy
+13,800
New +$580K ﹤0.01% 1803